$3.28
-0.250 (-7.08%)
At Close: Jun 03, 2026
SeaStar Medical Announces Appointment of Michael Messinger as CFO
08:43am, Monday, 17'th Nov 2025
DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing
SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates
04:05pm, Thursday, 13'th Nov 2025
Business highlights include: Three new top-rated children's hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI) Commercial use of QUELIMMUNE therapy demonstrates posi
VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge
08:21am, Tuesday, 11'th Nov 2025
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 11, 2025 / VSee Health, Inc. (Nasdaq:VSEE) a leader in HIPAA-compliant telemedicine solutions, leveraging its newly secured FedRAMP Moderate authoriza
SeaStar Medical (NASDAQ:ICU) Stock Price Down 2.7% – Here’s Why
03:39am, Thursday, 06'th Nov 2025
SeaStar Medical Holding Corporation (NASDAQ: ICU - Get Free Report) shares dropped 2.7% during mid-day trading on Wednesday. The company traded as low as $0.4220 and last traded at $0.5062. Approximat
SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025
10:03am, Wednesday, 05'th Nov 2025
DENVER, Nov. 05, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing
AlphaQuest LLC Acquires 1,468 Shares of ICU Medical, Inc. $ICUI
04:04am, Monday, 03'rd Nov 2025
AlphaQuest LLC boosted its holdings in ICU Medical, Inc. (NASDAQ: ICUI) by 3,058.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi
ICU Medical, Inc. (NASDAQ:ICUI) Given Average Recommendation of “Moderate Buy” by Analysts
04:00am, Wednesday, 29'th Oct 2025
ICU Medical, Inc. (NASDAQ: ICUI - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, MarketBeat reports. One equitie
Ondine Biomedical shares rise as ICU study shows strong infection-control results
06:21am, Monday, 27'th Oct 2025
Shares in Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) climbed 4% to 13p, extending their year-to-date gain to 44%, after the company reported encouraging results from its Steriwave ICU Pilot Study at R
ICU Medical Announces Time of Third Quarter 2025 Earnings Conference Call
08:30am, Thursday, 23'rd Oct 2025
SAN CLEMENTE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of
KLP Kapitalforvaltning AS Raises Holdings in ICU Medical, Inc. $ICUI
03:56am, Saturday, 18'th Oct 2025
KLP Kapitalforvaltning AS grew its position in shares of ICU Medical, Inc. (NASDAQ: ICUI) by 8.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commis
Data show results consistent with clinical trial experience A high level of safety – no device-related adverse events Strong survival data extending to 90 days
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
04:22pm, Wednesday, 24'th Sep 2025
Independent DSMB reports zero device-related safety issues Supports potential clinical benefit Trial sample size re-estimated to strengthen statistical power
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance
SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference
06:13pm, Thursday, 04'th Sep 2025
DENVER, Sept. 04, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin
DENVER, Sept. 02, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facin
Sign In
Buy ICU